Grace Therapeutics Analyst Price Targets - Benzinga

Grace Therapeutics Inc

GRCENASDAQ

Trade with Public

Trade with Public

$2.12

0.020.95%

At close: Sep 4, 5:00 PM EST

$2.08

-0.0199-0.95%

Pre-Market: 5:39 AM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Grace Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Grace Therapeutics (GRCE).

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$10Upside to Avg. PT+380.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 24, 2026	TD Cowen	Stacy Ku	PT Cut	Buy	$12→$8
Feb 18, 2025	HC Wainwright & Co.	Oren Livnat	Maintained	Buy	$12

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Grace Therapeutics, Lowers Price Target to $8

TD Cowen analyst Stacy Ku maintains Grace Therapeutics (NASDAQ:GRCE) with a Buy and lowers the price target from $12 to $8.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Grace Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Oren Livnat reiterates Grace Therapeutics (NASDAQ:GRCE) with a Buy and maintains $12 price target.

Benzinga Newsdesk